Tonix Pharmaceuticals Holding Corp.
TNXP
$17.82
$0.633.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -22.11M | -14.21M | -78.78M | -14.94M | -27.32M |
| Total Depreciation and Amortization | 972.00K | 510.00K | 967.00K | 972.00K | 1.50M |
| Total Amortization of Deferred Charges | -276.00K | 209.00K | 367.00K | 540.00K | -238.00K |
| Total Other Non-Cash Items | 366.00K | 1.32M | 62.70M | -5.31M | 3.36M |
| Change in Net Operating Assets | 6.42M | -6.63M | 4.82M | 1.17M | 363.00K |
| Cash from Operations | -14.63M | -18.80M | -9.92M | -17.58M | -22.34M |
| Capital Expenditure | -3.00K | -9.00K | 0.00 | -108.00K | -438.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 7.00K |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.00K | -9.00K | 0.00 | -108.00K | -431.00K |
| Total Debt Issued | -- | -- | -- | -- | 8.94M |
| Total Debt Repaid | -705.00K | -705.00K | -705.00K | -235.00K | -- |
| Issuance of Common Stock | 89.16M | 45.85M | 12.43M | 23.00K | 11.14M |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.30M | -2.24M | -4.70M | -- | 20.64M |
| Cash from Financing | 85.15M | 42.91M | 7.03M | -212.00K | 40.71M |
| Foreign Exchange rate Adjustments | 24.00K | -17.00K | 1.00K | -4.00K | -10.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.55M | 24.08M | -2.89M | -17.90M | 17.93M |